Development of clinical practice guidelines for allied health and nursing assessment and management of Duchenne muscular dystrophy

References

• Emery AE. Population frequencies of inherited neuromuscular diseases – a world survey. Neuromuscul Disord. 1991;1:19–29.
   PubMedGoogle Scholar
• Mendell JR, Shilling C, Leslie ND, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71:304–313.
   PubMed Web of Science ®Google Scholar
• Theadom A, Rodrigues M, Poke G, et al. A nationwide, population-based prevalence study of genetic muscle disorders. Neuroepidemiology. 2019;52:128–135.
   PubMed Web of Science ®Google Scholar
• Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.
   PubMed Web of Science ®Google Scholar
• Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12:926–929.
   PubMed Web of Science ®Google Scholar
• Gloss D, Moxley RT 3rd, Ashwal S, et al. Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86:465–472.
   PubMed Web of Science ®Google Scholar
• Passamano L, Taglia A, Palladino A, et al. Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol. 2012;31:121–125.
   PubMedGoogle Scholar
• Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347–361.
   PubMed Web of Science ®Google Scholar
• Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251–267.
   PubMed Web of Science ®Google Scholar
• Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17(5):445–455.
   PubMed Web of Science ®Google Scholar
• Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–189.
   PubMed Web of Science ®Google Scholar
• Brumbaugh D, Watne L, Gottrand F, et al. Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S53.
   PubMed Web of Science ®Google Scholar
• Case LE, Apkon SD, Eagle M, et al. Rehabilitation management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S17.
   PubMed Web of Science ®Google Scholar
• Weber DR, Hadjiyannakis S, McMillan HJ, et al. Obesity and endocrine management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S43.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926.
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines. Melbourne: National Health and Medical Research Council; 2011.
   Google Scholar
• Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–406.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–394.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549.
   PubMed Web of Science ®Google Scholar
• Physiotherapy Evidence Database (PEDro); 1999. Available from: https://www.pedro.org.au/wp-content/uploads/PEDro_scale.pdf
   Google Scholar
• Brouwers MKM, Browman GP, Burgers JS, et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010;182:E839–E842.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Nnacheta LC, Corrigan MD. Clinical consensus statement development manual. Otolaryngol Head Neck Surg. 2015;153:S1–S14.
   PubMed Web of Science ®Google Scholar
• Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation – determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66:726–735.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ. 2008;336:1049–1051.
   PubMed Web of Science ®Google Scholar
• Connolly AM, Malkus EC, Mendell JR, et al. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy. Muscle Nerve. 2015;51:522–532.
   PubMed Web of Science ®Google Scholar
• Escolar D, Henricson E, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve. 2001;24:787–793.
   PubMed Web of Science ®Google Scholar
• Mayhew JE, Florence JM, Mayhew TP, et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve. 2007;35:36–42.
   PubMed Web of Science ®Google Scholar
• McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48:357–368.
   PubMed Web of Science ®Google Scholar
• Goemans N, van den Hauwe M, Wilson R, et al. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul Disord. 2013;23:618–623.
   PubMed Web of Science ®Google Scholar
• Henricson E, Abresch R, Han JJ, et al. The 6-minute walk test and person-reported outcomes in boys with Duchenne muscular dystrophy and typically developing controls: longitudinal comparisons and clinically-meaningful changes over one year. PLoS Curr. 2013.
   Google Scholar
• Kempen J, Harlaar J, van der Kooi AJ, et al. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2014;24:216–221.
   PubMed Web of Science ®Google Scholar
• McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010;41(4):500–510.
   PubMed Web of Science ®Google Scholar
• Mazzone E, Martinelli D, Berardinelli A, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2010;20:712–716.
   PubMed Web of Science ®Google Scholar
• Aras B, Aras O, Karaduman A. Reliability of balance tests in children with Duchenne muscular dystrophy. Sci Res Essays. 2011;6:4428–4431.
   Google Scholar
• De Carvalho EV, Hukuda ME, Escorcio R, et al. Development and reliability of the functional evaluation scale for Duchenne muscular dystrophy, gait domain: a pilot study. Physiother Res Int. 2015;20(3):135–146.
   PubMed Web of Science ®Google Scholar
• Hukuda ME, Escorcio R, Fernandes LA, et al. Evaluation scale development, reliability for sitting and standing from the chair for Duchenne muscular dystrophy. J Motor Behav. 2013;45:117–126.
   PubMed Web of Science ®Google Scholar
• Escorcio R, Caromano FA, Hukuda ME, et al. Development of an evaluation scale for sitting and standing from the ground for children with Duchenne muscular dystrophy. J Motor Behav. 2011;43:31–36.
   PubMed Web of Science ®Google Scholar
• Fernandes LA, Caromano FA, Hukuda ME, et al. Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne muscular dystrophy. Rev Bras Fisioter. 2010;14(6):518–526.
   PubMedGoogle Scholar
• Lue Y-J, Su C-Y, Yang R-C, et al. Development and validation of a muscular dystrophy-specific functional rating scale. Clin Rehabil. 2006;20(9):804–817.
   PubMed Web of Science ®Google Scholar
• De Sanctis R, Pane M, Sivo S, et al. Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25(1):14–18.
   PubMed Web of Science ®Google Scholar
• Mayhew A, Cano S, Scott E, et al. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2011;53:535–542.
   PubMed Web of Science ®Google Scholar
• Mayhew AG, Cano SJ, Scott E, et al. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55:1046–1052.
   PubMed Web of Science ®Google Scholar
• Mazzone ES, Messina S, Vasco G, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord. 2009;19(7):458–461.
   PubMed Web of Science ®Google Scholar
• Scott E, Eagle M, Mayhew A, et al. Development of a Functional Assessment Scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int. 2012;17:101–109.
   PubMedGoogle Scholar
• Mayhew A, Mazzone ES, Eagle M, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55:1038–1045.
   PubMed Web of Science ®Google Scholar
• Pane M, Mazzone E, Fanelli L, et al. Reliability of the performance of upper limb assessment in Duchenne muscular dystrophy. Neuromuscul Disord. 2014;24:201–206.
   PubMed Web of Science ®Google Scholar
• Jansen M, De Jong M, Coes HM, et al. The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder. Muscle Nerve. 2012;46:520–530.
   PubMed Web of Science ®Google Scholar
• Berard C, Payan C, Hodgkinson I, et al. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15:463–470.
   PubMed Web of Science ®Google Scholar
• De Lattre C, Payan C, Vuillerot C, et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218–2226.
   PubMed Web of Science ®Google Scholar
• Vuillerot C, Girardot F, Payan C, et al. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the motor function measure. Dev Med Child Neurol. 2010;52(1):60–65.
   PubMed Web of Science ®Google Scholar
• Steffensen B, Hyde S, Lyager S, et al. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int. 2001;6(3):119–134.
   PubMedGoogle Scholar
• Steffensen BF, Hyde SA, Attermann J, et al. Reliability of the EK scale, a function test for non-ambulatory persons with Duchenne dystrophy. Adv Physiother. 2002;4(1):37–47.
   Google Scholar
• Nicot F, Hart N, Forin V, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006;174:67–74.
   PubMed Web of Science ®Google Scholar
• Elliott SA, Davidson ZE, Davies PS, et al. A bedside measure of body composition in Duchenne muscular dystrophy. Pediatr Neurol. 2015;52:82–87.
   PubMed Web of Science ®Google Scholar
• McDonald C, Carter G, Abresch R, et al. Body composition and water compartment measurements in boys with Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2005;84(7):483–491.
   PubMed Web of Science ®Google Scholar
• Mok E, Béghin L, Gachon P, et al. Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement. Am J Clin Nutr. 2006;83(1):65–69.
   PubMed Web of Science ®Google Scholar
• Mok E, Letellier G, Cuisset J, et al. Assessing change in body composition in children with Duchenne muscular dystrophy: anthropometry and bioelectrical impedance analysis versus dual-energy X-ray absorptiometry. Clin Nutr. 2010;29(5):633–638.
   PubMed Web of Science ®Google Scholar
• Elliott SA, Davidson ZE, Davies PS, et al. Accuracy of parent-reported energy intake and physical activity levels in boys with Duchenne muscular dystrophy. Nutr Clin Pract. 2015;30:297–304.
   PubMed Web of Science ®Google Scholar
• Archer SK, Garrod R, Hart N, et al. Dysphagia in Duchenne muscular dystrophy assessed objectively by surface electromyography. Dysphagia. 2013;28:188–198.
   PubMed Web of Science ®Google Scholar
• Archer S, Garrod R, Hart N, et al. Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire. Int J Lang Commun Disord. 2013;48:240–246.
   PubMed Web of Science ®Google Scholar
• Hendriksen JG, Poysky JT, Schrans DG, et al. Psychosocial adjustment in males with Duchenne muscular dystrophy: psychometric properties and clinical utility of a parent-report questionnaire. J Pediatr Psychol. 2009;34:69–78.
   PubMed Web of Science ®Google Scholar
• Kinali M, Main M, Eliahoo J, et al. Predictive factors for the development of scoliosis in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2007;11(3):160–166.
   PubMed Web of Science ®Google Scholar
• Garralda E, Muntoni F, Cunniff A, et al. Knee-ankle-foot orthosis in children with Duchenne muscular dystrophy: user views and adjustment. Eur J Paediatr Neurol. 2006;10:186–191.
   PubMed Web of Science ®Google Scholar
• Townsend EL, Tamhane H, Gross KD. Effects of AFO use on walking in boys with Duchenne muscular dystrophy: a pilot study. Pediatr Phys Ther. 2015;27:24–29.
   PubMed Web of Science ®Google Scholar
• Alemdaroglu I, Gur G, Bek N, et al. Is there any relationship between orthotic usage and functional activities in children with neuromuscular disorders? Prosthet Orthot Int. 2014;38:27–33.
   PubMed Web of Science ®Google Scholar
• Hyde S, Flytrup I, Glent S, et al. A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscul Disord. 2000;10:257–263.
   PubMed Web of Science ®Google Scholar
• Glanzman AM, Flickinger JM, Dholakia KH, et al. Serial casting for the management of ankle contracture in Duchenne muscular dystrophy. Pediatr Phys Ther. 2011;23:275–279.
   PubMed Web of Science ®Google Scholar
• Main M, Mercuri E, Haliloglu G, et al. Serial casting of the ankles in Duchenne muscular dystrophy: can it be an alternative to surgery? Neuromuscul Disord. 2007;17:227–230.
   PubMedGoogle Scholar
• Myers KA, Ramage B, Khan A, et al. Vibration therapy tolerated in children with Duchenne muscular dystrophy: a pilot study. Pediatr Neurol. 2014;51:126–129.
   PubMed Web of Science ®Google Scholar
• Soderpalm AC, Kroksmark AK, Magnusson P, et al. Whole body vibration therapy in patients with Duchenne muscular dystrophy – a prospective observational study. J Musculoskelet Neuronal Interact. 2013;13:13–18.
   PubMed Web of Science ®Google Scholar
• Vry J, Schubert IJ, Semler O, et al. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy. Eur J Paediatr Neurol. 2014;18(2):140–149.
   PubMed Web of Science ®Google Scholar
• Petryk A, Polgreen LE, Grames M, et al. Feasibility and tolerability of whole-body, low-intensity vibration and its effects on muscle function and bone in patients with dystrophinopathies: a pilot study. Muscle Nerve. 2017;55:875–883.
   PubMed Web of Science ®Google Scholar
• Clark J, Michael S, Morrow M. Wheelchair postural support for young people with progressive neuromuscular disorders. Int J Ther Rehabil. 2004;11(8):365–373.
   Google Scholar
• Bianchi M, Morandi L, Andreucci E, et al. Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin d treatment. Osteoporos Int. 2011;22:529–539.
   PubMed Web of Science ®Google Scholar
• Alshaikh N, Brunklaus A, Davis T, et al. Vitamin D in corticosteroid-naive and corticosteroid-treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels? Arch Dis Child. 2016;101(10):957–961.
   PubMed Web of Science ®Google Scholar
• Alemdaroglu I, Karaduman AA, Yilmaz O. Acute effects of different exercises on hemodynamic responses and fatigue in Duchenne muscular dystrophy. Fizyoter Rehabil. 2012;23:10–16.
   Google Scholar
• Alemdaroğlu I, Karaduman A, Yilmaz ÖT, et al. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation. Muscle Nerve. 2015;51(5):697–705.
   PubMed Web of Science ®Google Scholar
• Jansen M, van Alfen N, Geurts AC, et al. Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse". Neurorehabil Neural Repair. 2013;27(9):816–827.
   PubMed Web of Science ®Google Scholar
• Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev. 2013;2013(6):CD004760.
   Google Scholar
• Mok E, Alberti C, Letellier G, et al. Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial. PLoS One. 2009;4(5):e5448.
   PubMed Web of Science ®Google Scholar
• Escolar DM, Buyse G, Henricson E, et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol. 2005;58:151–155.
   PubMed Web of Science ®Google Scholar
• Abdel Meguid IE, Specker T, Smith R, et al. Effect of carnitine on muscle power and purine metabolism in Duchenne muscular dystrophy patients. Acta Myol. 2000;19:215–219.
   Google Scholar
• Escobar-Cedillo RE, Tintos-Hernandez JA, Martinez-Castro G, et al. l-Carnitine supplementation in Duchenne muscular dystrophy steroid-naive patients: a pilot study. Curr Top Nutraceut Res. 2013;11:97–101.
   Web of Science ®Google Scholar
• Spurney CF, Carolina TR, Henricson E, et al. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve. 2011;44:174–178.
   PubMed Web of Science ®Google Scholar
• Pellegrini N, Guillon B, Prigent H, et al. Optimization of power wheelchair control for patients with severe Duchenne muscular dystrophy. Neuromuscul Disord. 2004;14:297–300.
   PubMed Web of Science ®Google Scholar
• Kumar A, Frances Phillips M. Use of powered mobile arm supports by people with neuromuscular conditions. J Rehabil Res Dev. 2013;50:61–70.
   PubMedGoogle Scholar
• Cincotti F, Mattia D, Aloise F, et al. Non-invasive brain–computer interface system: towards its application as assistive technology. Brain Res Bull. 2008;75:796–803.
   PubMed Web of Science ®Google Scholar
• Chatwin M, Simonds AK. The addition of mechanical insufflation/exsufflation shortens airway-clearance sessions in neuromuscular patients with chest infection. Respir Care. 2009;54:1473–1479.
   PubMed Web of Science ®Google Scholar
• Stehling F, Bouikidis A, Schara U, et al. Mechanical insufflation/exsufflation improves vital capacity in neuromuscular disorders. Chronic Respir Dis. 2015;12:31–35.
   PubMed Web of Science ®Google Scholar
• Brito MF, Moreira GA, Pradella-Hallinan M, et al. Air stacking and chest compression increase peak cough flow in patients with Duchenne muscular dystrophy. J Bras Pneumol. 2009;35(10):973–979.
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Bach J, Komaroff E, et al. Cough augmentation in Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2008;87(9):726–730.
   PubMed Web of Science ®Google Scholar
• Kang SW, Kang YS, Moon JH, et al. Assisted cough and pulmonary compliance in patients with Duchenne muscular dystrophy. Yonsei Med J. 2005;46(2):233–238.
   PubMed Web of Science ®Google Scholar
• Kang SW, Kang YS, Sohn HS, et al. Respiratory muscle strength and cough capacity in patients with Duchenne muscular dystrophy. Yonsei Med J. 2006;47(2):184–190.
   PubMed Web of Science ®Google Scholar
• Toussaint M, Pernet K, Steens M, et al. Cough augmentation in subjects with Duchenne muscular dystrophy: comparison of air stacking via a resuscitator bag versus mechanical ventilation. Respir Care. 2016;61(1):61–67.
   PubMed Web of Science ®Google Scholar
• McKim D, Katz S, Barrowman N, et al. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2012;93(7):1117–1122.
   PubMed Web of Science ®Google Scholar
• Meric H, Falaize L, Pradon D, et al. Short-term effect of volume recruitment–derecruitment manoeuvre on chest-wall motion in Duchenne muscular dystrophy. Chronic Respir Dis. 2017;14:110–116.
   PubMed Web of Science ®Google Scholar
• Bach JR, Bianchi C, Vidigal-Lopes M, et al. Lung inflation by glossopharyngeal breathing and "air stacking" in Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2007;86(4):295–300.
   PubMed Web of Science ®Google Scholar
• Takaso M, Nakazawa T, Imura T, et al. Preoperative inspiratory muscle training for patients with severe scoliosis and high-risk pulmonary dysfunction in Duchenne muscular dystrophy. Eur J Orthop Surg Traumatol. 2010;20(2):113–121.
   Google Scholar
• Topin N, Matecki S, Bris S, et al. Dose-dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord. 2002;12:576–583.
   PubMed Web of Science ®Google Scholar
• Winkler G, Zifko U, Nader A, et al. Dose-dependent effects of inspiratory muscle training in neuromuscular disorders. Muscle Nerve. 2000;23(8):1257–1260.
   PubMed Web of Science ®Google Scholar
• Toussaint M, Steens M, Wasteels G, et al. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J. 2006;28:549–555.
   PubMed Web of Science ®Google Scholar
• Martigne L, Seguy D, Pellegrini N, et al. Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr. 2010;29(1):60–64.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Komaki H, Sasaki M, et al. Efficacy and tolerance of gastrostomy feeding in Japanese muscular dystrophy patients. Brain Dev. 2012;34:756–762.
   PubMed Web of Science ®Google Scholar
• Elliott SA, Davidson ZE, Davies PS, et al. Predicting resting energy expenditure in boys with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2012;16:631–635.
   PubMed Web of Science ®Google Scholar
• Soutter J, Hamilton N, Russell P, et al. The Golden Freeway: a preliminary evaluation of a pilot study advancing information technology as a social intervention for boys with Duchenne muscular dystrophy and their families. Health Soc Care Community. 2004;12:25–33.
   PubMed Web of Science ®Google Scholar
• Højberg AL, Jeppesen J. Examining the effect of networks for students with special educational needs. Scand J Disabil Res. 2012;14(2):126–147.
   Google Scholar
• Hodges L, Dibb B. Social comparison within self-help groups: views of parents of children with Duchenne muscular dystrophy. J Health Psychol. 2010;15:483–492.
   PubMed Web of Science ®Google Scholar
• Hoskin J, Fawcett A. Improving the reading skills of young people with Duchenne muscular dystrophy in preparation for adulthood. Br J Spec Educ. 2014;41(2):172–190.
   Google Scholar
• Mullender M, Blom N, De Kleuver M, et al. A Dutch guideline for the treatment of scoliosis in neuromuscular disorders. Scoliosis. 2008;3:14.
   PubMedGoogle Scholar
• Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170:456–465.
   PubMed Web of Science ®Google Scholar
• Hull J. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness: commentary. Thorax. 2012;67:654–655.
   PubMed Web of Science ®Google Scholar
• Paguinto SG, Kasparian NA, Bray P, et al. Multidisciplinary perspectives and practices of wheelchair prescription for children with neuromuscular conditions. Disabil Rehabil Assist Technol. 2020;1–9.
   Google Scholar
• Pavan S, Rommel K, Mateo Marquina ME, et al. Clinical practice guidelines for rare diseases: the Orphanet database. PLoS One. 2017;12:e0170365.
   PubMed Web of Science ®Google Scholar
• Pai M, Yeung CHT, Akl EA, et al. Strategies for eliciting and synthesizing evidence for guidelines in rare diseases. BMC Med Res Methodol. 2019;19(1):67.
   PubMedGoogle Scholar
• Hilton BM, Harbour J, Ritchie K, et al. Report of an international workshop to explore the utility of the AGREE II instrument for appraisal of rare disease guidelines. Rare Dis Orphan Drugs. 2015;2:11–15.
   Google Scholar
• Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
   PubMed Web of Science ®Google Scholar
• Lochmüller H, Farnell JTI, Cam YL, et al. The International Rare Diseases Research Consortium: policies and guidelines to maximize impact. Eur J Hum Genet. 2017;25(12):1293–1302.
   PubMed Web of Science ®Google Scholar
• Golenko X, Pager S, Holden L. A thematic analysis of the role of the organisation in building allied health research capacity: a senior managers' perspective. BMC Health Serv Res. 2012;12:276.
   PubMed Web of Science ®Google Scholar
• Pager S, Holden L, Golenko X. Motivators, enablers, and barriers to building allied health research capacity. J Multidisc Healthc. 2012;5:53–59.
   PubMedGoogle Scholar
• Wenke RJ, Mickan S, Bisset L. A cross sectional observational study of research activity of allied health teams: is there a link with self-reported success, motivators and barriers to undertaking research? BMC Health Serv Res. 2017;17:114.
   PubMed Web of Science ®Google Scholar
• Turner T, Misso M, Harris C, et al. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci. 2008;3:45.
   PubMed Web of Science ®Google Scholar
• Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53.
   PubMed Web of Science ®Google Scholar
• Atkins L, Francis J, Islam R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12:77.
   PubMed Web of Science ®Google Scholar
• Needham DM. Translating evidence into practice: a model for large scale knowledge translation. Br Med J. 2008;337:963–965.
   Google Scholar
• Jacobson N, Butterill D, Goering P. Development of a framework for knowledge translation: understanding user context. J Health Serv Res Policy. 2003;8:94–99.
   PubMedGoogle Scholar
• Hakkennes S, Dodd K. Guideline implementation in allied health professions: a systematic review of the literature. Qual Saf Health Care. 2008;17:296–300.
   PubMed Web of Science ®Google Scholar
• Scott SD, Albrecht L, O’Leary K, et al. Systematic review of knowledge translation strategies in the allied health professions. Implement Sci. 2012;7:70.
   PubMed Web of Science ®Google Scholar
• Hitch D, Pepin G, Stagnitti K. The Integrating Theory, Evidence and Action (ITEA) method: a procedure for helping practitioners translate theory and research into action. Br J Occup Ther. 2014;77(12):592–600.
   Web of Science ®Google Scholar